- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Sandu Pharmaceuticals Ltd — Board Meeting, 12-11-2025: Board Meeting
12-11-2025 | 05:42 pm
12-11-2025 | 05:42 pm
Sandu Pharma's board has approved the financial results for the quarter and half-year ended Sept 30. Q2 Revenue stood at ₹17.62 Cr, with profit at ₹0.52 Cr. For H1, revenue was ₹34.32 Cr and profit ₹0.75 Cr. The Audit Committee reviewed the results.
No comments yet. Be the first to comment!